HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States.

AuthorsSourya Shrestha, Andrea Parriott, Nicolas A Menzies, Priya B Shete, Andrew N Hill, Suzanne M Marks, David W Dowdy
JournalAnnals of the American Thoracic Society (Ann Am Thorac Soc) Vol. 17 Issue 12 Pg. 1639-1642 (12 2020) ISSN: 2325-6621 [Electronic] United States
PMID32916062 (Publication Type: Letter, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antitubercular Agents
  • Isoniazid
  • Rifampin
  • rifapentine
Topics
  • Antitubercular Agents (therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Isoniazid
  • Latent Tuberculosis (drug therapy, epidemiology)
  • Rifampin (analogs & derivatives)
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: